Sumathi Memorial Trust was established in the memory of Mrs. Sumathi Velumani – co-creator of Thyrocare.
Mrs. Velumani’s personality was characterized by steely resolve, frugality and a deep sense of caring and compassion – she created a lot of wealth but did not consume any. Thyrocare’s journey to become one of the fastest growing healthcare companies in India with a market cap of over 4,000 crores is owed in no small part to her nurturing of the business and the people.
She was a victim of late diagnosis of pancreatic cancer – which claimed her prematurely in early 2016. This Trust has been created by her family to tackle the twin problems of undiagnosed and unmonitored cancer – which lead to high mortality rates in India (>95%). The Trust aims to help patients suffering from cancer across India in whatever way possible.
PET/CT scans are a cutting-edge technology and are globally accepted as the definitive cancer management tool, but the high costs of scanning facilities lead to unaffordable prices, routinely in excess of INR 20,000. SMT is working to help alleviate the large financial burden of cancer treatments, and will pay for each patient, when they undergo a PET/CT Scans, an amount of INR 3,000.
The Trust aims to subsidize a million scans before March 2025.